| Metric | Current | Prior | YoY |
|---|---|---|---|
| Revenue | ¥170.3B | ¥237.4B | -28.3% |
| Operating Income | ¥29.3B | ¥63.0B | -53.5% |
| Ordinary Income | ¥41.9B | ¥72.9B | -42.5% |
| Net Income | ¥29.9B | ¥52.8B | -43.4% |
| ROE | 3.8% | 7.1% | - |
FY2026 Q3 results showed significant contraction with revenue of ¥170.3B (YoY -28.3%), operating income of ¥29.3B (YoY -53.5%), ordinary income of ¥41.9B (YoY -42.5%), and net income of ¥29.9B (YoY -43.4%). Despite maintaining a high operating margin of 17.2%, the substantial revenue decline drove profit compression across all levels. Non-operating income contributed ¥12.6B net, primarily from dividend income of ¥7.9B and extraordinary gains from securities sales of ¥2.9B, partially offsetting the operating profit decline. Comprehensive income reached ¥69.4B, boosted by ¥39.5B in unrealized gains on investment securities. The company maintains exceptionally strong liquidity with a current ratio of 930.4% and equity ratio of 88.0%, though working capital metrics show concerning deterioration with inventory surging 113.0% YoY to ¥40.4B and work-in-process ballooning to ¥122.8B.
Revenue declined 28.3% YoY from ¥237.4B to ¥170.3B, representing a substantial top-line contraction. The cost of sales decreased proportionally less at 22.8% to ¥113.4B, resulting in gross profit of ¥56.8B with a maintained gross margin of 33.4%. SG&A expenses declined 14.7% to ¥27.6B (16.2% of revenue), demonstrating some cost control but insufficient to offset the revenue decline impact. The 28.3% revenue decrease combined with only 14.7% SG&A reduction indicates operating leverage working in reverse, with fixed cost burdens intensifying. Operating income fell 53.5% to ¥29.3B, yielding a still-healthy operating margin of 17.2%, though down from prior year levels.
At the ordinary income level, non-operating items provided significant support. Non-operating income totaled ¥13.1B, comprising dividend income of ¥7.9B, interest income of ¥0.9B, and FX gains of ¥1.3B, while non-operating expenses were minimal at ¥0.5B. This resulted in a net non-operating contribution of ¥12.6B, representing 7.4% of revenue and materially cushioning the operating profit decline. Ordinary income of ¥41.9B exceeded operating income by 43.0%, indicating substantial reliance on non-operating sources. Extraordinary items added net ¥2.4B, mainly from securities sales gains of ¥2.9B offset by asset disposal losses of ¥0.5B. After tax expense of ¥11.6B (effective tax rate 28.0%), net income settled at ¥29.9B.
The performance pattern represents revenue down/profit down, with profit declining at a steeper rate than revenue due to negative operating leverage and diminished economies of scale. The company's profitability was supported by substantial non-operating income from its investment portfolio rather than core operational strength.
[Profitability] ROE of 3.8% represents significantly weak capital efficiency, well below manufacturing industry standards, driven primarily by an exceptionally low asset turnover of 0.190x despite maintaining a high net profit margin of 17.5%. Operating margin stood at 17.2%, demonstrating strong pricing power and cost structure at the operational level, though substantially elevated from the industry median of 8.9%. ROIC of 3.4% falls critically below acceptable thresholds, indicating inefficient capital allocation and underutilization of invested capital. [Cash Quality] Cash and deposits totaled ¥170.9B against current liabilities of ¥48.1B, providing cash coverage of 3.55x and demonstrating substantial short-term liquidity despite operational challenges. The comprehensive income of ¥69.4B exceeded net income by 132%, driven by ¥39.5B in unrealized securities gains, indicating significant mark-to-market benefits supporting shareholder equity. [Investment Efficiency] Asset turnover of 0.190x compares unfavorably to the industry median of 0.56x, reflecting significant asset bloat particularly in inventory and investment securities. Working capital turnover deteriorated substantially with inventory days reaching extreme levels and work-in-process representing 62.8% of total inventory at ¥122.8B, signaling manufacturing bottlenecks or demand misalignment. [Financial Health] Equity ratio of 88.0% substantially exceeds the industry median of 63.8%, indicating an extremely conservative capital structure with minimal leverage. Current ratio of 930.4% versus industry median of 2.87x demonstrates exceptional short-term solvency, though this strength is partially offset by working capital inefficiencies. Financial leverage of 1.14x compares favorably to the industry median of 1.53x, reflecting minimal debt utilization. Debt-to-equity ratio remains negligible with total liabilities of ¥107.4B against equity of ¥787.3B, providing substantial financial flexibility.
Cash and deposits increased ¥10.4B YoY to ¥170.9B, representing 19.1% of total assets and providing substantial liquidity cushion. The balance sheet reflects significant working capital expansion with inventories surging ¥21.4B to ¥40.4B and work-in-process ballooning to ¥122.8B, together representing substantial cash conversion delays. Trade receivables increased to ¥74.5B, indicating extended collection cycles. Investment securities expanded dramatically by ¥76.9B to ¥254.2B, consuming significant capital and contributing to comprehensive income through unrealized gains of ¥39.5B. On the liability side, trade payables increased ¥11.1B to ¥27.0B, providing some natural financing benefit through extended payment terms. The company maintains no material interest-bearing debt with deferred tax liabilities of ¥54.1B representing the primary non-current obligation. Despite net income of ¥29.9B, the substantial working capital build particularly in inventory and receivables suggests cash generation from operations faced pressure. The cash coverage of short-term liabilities stands at 3.55x, indicating adequate near-term liquidity to meet obligations. The funding structure remains highly conservative with equity financing dominating the capital base.
Ordinary income of ¥41.9B versus operating income of ¥29.3B indicates non-operating net contribution of approximately ¥12.6B, representing 30.1% of ordinary income and 7.4% of revenue. This comprises primarily dividend income of ¥7.9B, interest income of ¥0.9B, and FX gains of ¥1.3B, with minimal non-operating expenses of ¥0.5B. The substantial reliance on investment income highlights limited core operational profit generation relative to total earnings. Extraordinary gains of ¥2.9B from securities sales further boosted pre-tax income to ¥41.5B. Non-operating and extraordinary items collectively contributed ¥15.0B or 50.3% of total pre-tax income, indicating significant earnings derived from non-recurring or investment-related sources rather than sustainable operations. While the operating margin of 17.2% demonstrates strong core business profitability, the 28.3% revenue decline raises concerns about volume sustainability. Comprehensive income of ¥69.4B substantially exceeded net income due to ¥39.5B in unrealized securities valuation gains, introducing volatility and dependency on market conditions. The extreme inventory buildup with work-in-process at ¥122.8B and finished goods at ¥40.4B totaling ¥163.2B suggests potential accrual-based earnings risks from inventory valuation. Without operating cash flow disclosure, the cash backing of reported earnings remains unverified, though the substantial non-operating income from dividends and securities likely provides cash elements. Overall earnings quality shows mixed characteristics with strong operating margins offset by revenue weakness, significant non-operating dependency, and working capital deterioration requiring monitoring.
Progress against full-year guidance shows revenue achievement of 64.0% (¥170.3B actual vs ¥266.0B forecast), operating income at 71.5% (¥29.3B vs ¥41.0B), and ordinary income at 79.1% (¥41.9B vs ¥53.0B) through Q3. With Q3 representing approximately 75% of the fiscal year, revenue progress of 64.0% trails standard expectations by 11 percentage points, indicating potential full-year shortfall risk unless Q4 delivers substantial acceleration. Operating income progress of 71.5% shows better relative performance despite absolute decline, suggesting cost management initiatives may improve profitability in the final quarter. The company has not revised guidance this quarter, maintaining full-year targets of ¥266.0B revenue (YoY -14.7%), ¥41.0B operating income (YoY -39.9%), and ¥53.0B ordinary income (YoY -31.3%). The unchanged forecast despite Q3 underperformance suggests management confidence in Q4 recovery or conservative prior guidance. Implied Q4 requirements include ¥95.7B revenue and ¥11.7B operating income, representing significant sequential acceleration from Q3 run rates. The forecasted EPS of ¥179.57 and annual dividend of ¥50.00 remain unchanged, implying a forward payout ratio of 27.8% based on full-year earnings expectations, substantially lower than the current 69.3% ratio calculated on Q3 trailing results. Key assumptions underlying the forecast are not detailed in available disclosures but likely incorporate anticipated demand recovery and inventory normalization in the final quarter.
The company forecasts an annual dividend of ¥50.00 comprising interim dividend of ¥50.00 and expected year-end dividend of ¥50.00, maintaining the prior year level. Based on current net income of ¥29.9B and 20,048K average shares outstanding, the calculated payout ratio stands at approximately 69.3% using trailing results. However, applying the full-year earnings forecast of ¥179.57 per share yields a forward payout ratio of 27.8%, indicating management's confidence in full-year earnings recovery to support the dividend sustainably. The dividend yield based on EPS guidance suggests stable shareholder returns despite current period earnings pressure. No share buyback programs were disclosed for the current period, making the total return ratio equivalent to the dividend payout ratio. The substantial divergence between current period payout ratio of 69.3% and forward guidance-based 27.8% highlights the importance of Q4 earnings delivery to dividend sustainability. With cash and deposits of ¥170.9B and minimal debt, the company maintains substantial financial capacity to support dividends even if earnings recovery lags, though extended high payout ratios would warrant monitoring. The unchanged dividend forecast signals management commitment to shareholder returns despite operational headwinds.
Revenue sustainability risk stems from the severe 28.3% YoY decline to ¥170.3B, indicating significant demand weakness or competitive pressure in core carbon products markets. The 64.0% progress rate against full-year guidance through Q3 suggests risk of missing revenue targets without substantial Q4 acceleration, potentially impacting both profitability and cash generation.
Working capital deterioration presents acute operational risk with inventory surging 113.0% to ¥40.4B and work-in-process ballooning to ¥122.8B, representing 62.8% of total inventory. Combined with receivables of ¥74.5B, this working capital buildup suggests manufacturing bottlenecks, demand forecasting errors, or customer payment delays. Inventory turnover days far exceeding industry norms create obsolescence risk and cash conversion pressure.
Earnings quality risk arises from substantial dependence on non-operating income, with ¥12.6B net contribution (30.1% of ordinary income) from dividends, interest, and FX gains, plus ¥2.9B extraordinary gains from securities sales. This reliance on investment portfolio performance and non-recurring items rather than core operations creates sustainability concerns. Additionally, comprehensive income of ¥69.4B driven by ¥39.5B unrealized securities gains introduces mark-to-market volatility exposure, with potential for reversals under adverse market conditions impacting reported equity and potentially dividend capacity.
[Industry Position] (Reference - Proprietary Analysis)
Profitability: The company's ROE of 3.8% significantly underperforms the manufacturing industry median of 5.8%, placing it in the lower quartile for capital efficiency. This weak performance stems from exceptionally low asset turnover of 0.190x versus industry median of 0.56x, despite superior margins. Operating margin of 17.2% substantially exceeds the industry median of 8.9%, demonstrating strong operational pricing power and cost structure. Net profit margin of 17.5% similarly outperforms the industry median of 6.5% by 11.0 percentage points, ranking in the top quartile. However, ROIC of 3.4% falls below the industry median of 6.0%, indicating inefficient capital deployment offsetting margin advantages.
Financial Health: Equity ratio of 88.0% substantially exceeds the industry median of 63.8%, positioning the company among the most conservatively capitalized in the sector with minimal financial risk. Current ratio of 930.4% far surpasses the industry median of 2.87x, indicating exceptional short-term liquidity though potentially suggesting inefficient capital utilization. Financial leverage of 1.14x compares favorably to the industry median of 1.53x, reflecting minimal debt usage.
Efficiency: Asset turnover of 0.190x significantly trails the industry median of 0.56x, placing the company in the bottom decile for asset productivity. Working capital metrics show severe deterioration with inventory turnover days and receivables collection substantially exceeding industry norms. Revenue growth of -28.3% dramatically underperforms the industry median of +2.8%, indicating market share loss or end-market contraction. The company's operational efficiency challenges center on asset utilization and working capital management rather than margin realization.
※ Industry: Manufacturing (105 companies), Comparison: 2025-Q3 period, Source: Proprietary analysis
Strong margin profile undermined by operational execution challenges: The company maintains premium operating margins of 17.2% and net margins of 17.5%, both ranking in the top quartile versus manufacturing peers, demonstrating pricing power and operational cost efficiency at the unit level. However, this margin strength is overwhelmed by severe revenue contraction of 28.3% and asset turnover deterioration to 0.190x (vs. industry 0.56x), resulting in below-peer ROE of 3.8% and critically low ROIC of 3.4%. The disconnect between superior profitability ratios and weak return metrics indicates structural inefficiency in capital deployment and scale utilization requiring fundamental operational review.
Working capital crisis signals manufacturing or demand disruption: The 113.0% surge in inventory to ¥40.4B combined with work-in-process explosion to ¥122.8B (62.8% of total inventory) represents an acute operational anomaly inconsistent with the 28.3% revenue decline. This inverse relationship between sales contraction and inventory expansion suggests either significant manufacturing process disruptions, substantial demand forecast errors, or strategic inventory pre-positioning for anticipated recovery. The extreme working capital absorption creates cash conversion risk and potential for inventory write-downs if demand remains weak. Resolution of this working capital imbalance is critical to restoring cash generation and validating earnings quality.
Investment income dependency creates earnings sustainability questions: Non-operating income of ¥12.6B contributed 30.1% of ordinary income, with additional extraordinary gains of ¥2.9B from securities sales, making nearly half of pre-tax earnings dependent on investment portfolio performance rather than core operations. While the ¥254.2B investment securities portfolio (28.4% of assets) provides diversification and contributed ¥39.5B unrealized gains to comprehensive income, this structure creates earnings volatility exposure and raises questions about optimal capital allocation. The 69.3% dividend payout ratio based on current earnings versus 27.8% on full-year guidance highlights dependency on earnings recovery for dividend sustainability, though substantial cash reserves of ¥170.9B and 88.0% equity ratio provide near-term financial flexibility.
This report was automatically generated by AI analyzing XBRL earnings data as an earnings analysis tool. This is not a recommendation to invest in any specific security. Industry benchmarks are reference information compiled from publicly available earnings data. Please make investment decisions at your own responsibility and consult professionals as needed.